Bilateral nonpalpable breast carcinomas in a patient with BRCA2 germ line mutation and past history of osteosarcoma

Breast Cancer

Volumn 6, Issue 1, 1999, Pages 51-54

  Kuno, Toshiya ^a   Fukutomi, Takashi ^a   Akashi Tanaka, Sadako ^a   Nanasawa, Takeshi ^a   Kanai, Yae ^b   Tsuda, Hitoshi ^b   Nomizu, Tadashi ^c   Miki, Yoshio ^d  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c HOSHI GENERAL HOSPITAL   (Japan)

^d CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

BRCA2; Hereditary breast cancer; Histological grade; Osteosarcoma

Indexed keywords

EID: 1842626854     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966906     Document Type: Article

References (11)

1. Schubert EL, Lee MK, Mefford HC, et al: BRCA2 in American families with four or more cases of breast or ovarian cancer; Recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet 60:1031-1040, 1997. (Pubitemid 27194087)
2. Akashi TS, Fukutomi T, Miyakawa K, et al: Diagnostic value of enhanced computed tomography in the detection of the widely spreading intraductal component of breast cancer; Case reports. Breast Cancer 4:29-32, 1997.
3. Inoue R, Ushijima T, Fukutomi T, et al: BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 74:199-204, 1997. (Pubitemid 27234511)
4. Nomizu T, Tsuchiya A, Abe R, et al: Clinicopathological study of hereditary breast cancer in Japan. Jpn J Cancer Clin 44 (4):433-440, 1998.
5. Fukutomi T, Ushijima T, Inoue R, et al: BRCA1 and BRCA2 germline mutations in Japanese with hereditary breast cancer families. Breast Cancer 4:256-258, 1997.
6. Marcus JN, Watson P, Page DL, et al: Hereditary breast cancer; Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage [see comments]. Cancer 77:697-709, 1996. (Pubitemid 26055395)
7. Bieche I, Nogues C, Rivoilan S, et al: Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma. Br J Cancer 76:1416-1418, 1997. (Pubitemid 27501122)
8. Schrag D, Kuntz KM, Garber JE, et al: Decision analysis; Effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations [see comments]. N Engl J Med 336:1465-1471, 1997. (Pubitemid 27208615)
9. [published erratum appears in N Engl J Med 1997 Aug. 7; 337 (6):434]
10. Mann GB, Borgen PI, et al: Breast cancer genes and the surgeon. J Surg Oncol 67:267-274, 1998. (Pubitemid 28196920)
11. Geller G, Bernhardt BA, Doksum T, et al: Decisionmaking about breast cancer susceptibility testing; How similar are the attitudes of physicians, nurse practitioners, and at-risk women? J Clin Oncol 16:2868-2876, 1998. (Pubitemid 28363054)